Search
for
Sort by
Research 30 of 1000+
- Factors affecting the course and severity of adult acne. Observational cohort study
- Skin Epidermis and Adnexa Regrowth Induced by Treatment With Artificial Dermal Template After Full-Thickness Skin Wound
- Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey
- Cost-effectively dissecting the genetic architecture of complex wool traits in rabbits by low-coverage sequencing
- Nanoemulsion Vehicles as Carriers for Follicular Delivery of Luteolin
- Can UK undergraduate dental programmes provide training in non-surgical facial aesthetics?
- De novo assembly and annotation of Asiatic lion (<i>Panthera leo persica</i>) genome
- Molecular and spatial design of early skin development
- Back to the beginning: a retrospective review of the early <i>Forums</i>
- Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials
- Fondation René Touraine
- Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families
- Objective outcome measures: Collecting meaningful data on alopecia areata
- The Use of Therapeutic Peptides in Combination with Full-Thickness Skin Columns to Improve Healing of Excisional Wounds
- Multi-faceted enhancement of full-thickness skin wound healing by treatment with autologous micro skin tissue columns
- Enhancing Lower Extremity Defect Coverage: High Viability Ultra-Thin Split-Thickness Skin Grafts Obtained from the Scalp
- Gender Surgery Beyond Chest and Genitals: Current Insurance Landscape
- Shengfu Oil Enhances the Healing of Full-Thickness Scalded Skin Accompanying the Differential Regulation of β-Catenin, Dlk1, and COX-2
- Fish Acellular Dermal Matrix Promotes Repair of Full‐Thickness Skin Defects in Mice and Bama Pigs
- Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Patients, Power and Responsibility
- Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
- Evaluation of Stigma Toward Individuals With Alopecia
- Efficacy and Safety of Mesotherapy With 0.5% Minoxidil Versus Topical 2% Minoxidil for Female Androgenetic Alopecia: A Randomized Controlled Trial
- Subcutaneous injection of genetically engineered exosomes for androgenic alopecia treatment
- Dermatology Patient Support Groups
- Advantages of Incomplete Digestion in Human Hair Shaft Proteomics, a Focus on Cuticular Keratins
- The Basic Science of Hair Biology